Strontium malonate

DB05732InvestigationalSmall molecule

Strontium malonate is being developed as a novel orally available pharmaceutical for the treatment and prevention of osteoporosis. It is being developed by Osteologix Inc.

Chemical structure of Strontium malonate
Primary indication
Investigated for use/treatment in osteoporosis.Curator reviewed
Formula / weight
C3H2O4Sr · 189.67 g/mol (avg)
Code names
NB S101

Resolves to

Compound
UNIIGT5D7PW9ZRCAS183133-72-4
Structure
InChIKeyLVZZABGEQTZXHP-UHFFFAOYSA-LSMILES[Sr++].[O-]C(=O)CC([O-])=O

What you can answer from here — as of June 12, 2020

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Strontium malonate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In